Recapitalization reduced net debt to $14 million as of October 31; achieved key milestones to deliver potential 2026 revenue targetBERKELEY, ...
“These results establish the CssDNA process as an efficient non-viral gene insertion strategy, and mark a pivotal advance towards the development of next-generation cell and gene therapies” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback